Showing results 21 to 36 of 36
< previous
| Issue Date | Title | Author(s) |
| 2012 | A novel agent, KL-21, has significant anticancer potential on chronic lymphocytic leukemia cells but not on healthy cells | Baran, Yusuf ; Gökbulut, Aysun ; Yaşar, M. |
| Jan-2013 | Novel agents targeting bioactive sphingolipids for the treatment of cancer | Adan Gökbulut, Aysun ; Kartal Yandım, Melis; İskender, Güniz; Baran, Yusuf |
| 2015 | A novel natural product, KL-21, inhibits proliferation and induces apoptosis in chronic lymphocytic leukemia cells | Adan Gökbulut, Aysun ; Yaşar, Mustafa; Baran, Yusuf |
| Nov-2015 | The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks | Adan, Aysun ; Baran, Yusuf |
| 2013 | Purification and biochemical characterization of an extracellular lipase from psychrotolerant Pseudomonas fluorescens KE38 | Adan Gökbulut, Aysun ; Arslanoğlu, Alper |
| 2012 | Quercetin induced apoptosis in 232B4 chronic lymphocytic leukemia cells | Baran, Yusuf ; Gökbulut, Aysun ; Apohan, Elif; Pişkin, Özden; Özcan, Mehmet Ali |
| 2013 | Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest | Adan Gökbulut, Aysun ; Apohan, Elif; Baran, Yusuf |
| Sep-2015 | Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted “hsa-miR-2278” as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A | Tezcanlı Kaymaz, Burçin; Selvi Günel, Nur; Ceyhan, Metin; Bozok Çetintaş, Vildan; Özel, Buket; Kartal Yandım, Melis; Kıpçak, Sezgi; Aktan, Çağdaş; Adan Gökbulut, Aysun ; Baran, Yusuf ; Kosova Can, Buket |
| 2015 | Sphingosine-1-phosphate receptor 2/GQ/Phospholıpase C Axis is a novel mechanism to overcome nilotinib resistance in T315I mutation expressing 32DCL3 murine cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
| Jul-2013 | STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells | Kiper, Hatice Demet; Tezcanlı Kaymaz, Burçin; Adan Gökbulut, Aysun ; Selvi, Nur; Biray Avcı, Çığır; Kosova, Buket; İskender, Güniz; Kartal Yandım, Melis; Gündüz, Cumhur; Şahin, Fahri; Baran, Yusuf ; Saydam, Güray |
| 2014 | Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosis | Tezcanlı Kaymaz, Burçin; Selvi, Nur; Adan Gökbulut, Aysun ; Aktan, Çağdaş; Gündüz, Cumhur; Saydam, Güray; Baran, Yusuf ; Kosova, Buket |
| 2014 | Targeting sphingosine kinase-1/spingosine-1-phosphate receptor 2 signalling pathway to overcome T315I mutation in 32DCL3 cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
| May-2014 | Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells | Solmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf |
| 2015 | Therapeutic potential of fisetin and identification of its mechanisms in action in chronic myeloid leukemia and acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2014 | Therapeutic potential of fisetin, vitexin and hesperetin on chronic myeloid leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2015 | Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute myeloid leukemia cells | Adan Gökbulut, Aysun |
